Clinical Trials Browser

Prostatic Neoplasms, Castration-Resistant × darolutamide × 1 year × Clear all

NCT05997615 2026-02-24

AMX-500

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05519449 2026-01-20

ENGAGER-PSMA-01

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06190899 2025-03-21

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant